| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular Medicine |
i2 Expression in Cultured Atrial Cells
From the Cardiovascular Division (H.-J.P., U.B., D.K., H.Y., J.B.G.), Department of Medicine, Brigham and Womens Hospital and Harvard Medical School, Boston, Mass; the Department of Molecular Biology and Biochemistry (T.F.O.), University of California-Irvine, Irvine, Calif; and the Department of Biochemistry and Molecular Pharmacology (L.Y., F.B.H.), School of Medicine, West Virginia University, Morgantown, WV.
Correspondence to Jonas B. Galper, Dept of Medicine, Cardiovascular Division, Brigham and Womens Hospital, 75 Francis St, Boston, MA 02115. E-Mail Galper@ calvin.bwh.harvard.edu
We have previously demonstrated that growth of embryonic chick atrial cells in medium supplemented with lipoprotein-depleted serum (LPDS) resulted in a coordinate increase in the expression of genes involved in the parasympathetic response of the heart (the M2 muscarinic receptor; the
-subunit of the heterotrimeric G protein, G
i2; and the inward rectifying K+ channel protein, GIRK1) and a marked increase in the negative chronotropic response of atrial cells to muscarinic stimulation. In the present study, we demonstrate that regulation of G
i2 promoter activity by LPDS is mediated by the binding of a sterol regulatory element binding protein (SREBP) to a sterol regulatory element (SRE) in the G
i2 promoter. Deletion and point mutation of this putative SRE interfered with the regulation of the G
i2 promoter by SREBP and LPDS. Furthermore gel shift assays demonstrated that point mutations in the putative G
i2 SRE markedly inhibited the binding of purified SREBP to oligonucleotides containing the G
i2 SRE sequence. The expression of a dominant-negative SREBP mutant interfered with LPDS stimulation of G
i2 promoter activity. Finally, we demonstrate that SREBP-1 is markedly more potent than SREBP-2 for the stimulation of G
i2 promoter activity, suggesting that SREBP1 may play a role in the regulation of G
i2 expression. These are the first data to demonstrate SREBP regulation of a protein not involved in lipid homeostasis and suggest a new relationship between lipid metabolism and the parasympathetic response of the heart.
Key Words: sterol regulatory element binding proteins parasympathetic response of the heart G proteins G
i2
This article has been cited by other articles:
![]() |
H.-J. Park, Y. Zhang, C. Du, C. M. Welzig, C. Madias, M. J. Aronovitz, S. P. Georgescu, I. Naggar, B. Wang, Y.-B. Kim, et al. Role of SREBP-1 in the Development of Parasympathetic Dysfunction in the Hearts of Type 1 Diabetic Akita Mice Circ. Res., July 31, 2009; 105(3): 287 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zuberi, L. Birnbaumer, and A. Tinker The role of inhibitory heterotrimeric G proteins in the control of in vivo heart rate dynamics Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1822 - R1830. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |